| Financial Year |
March 31 2023 |
| Monetary Funds |
406,927,697.36 |
| Held-for-trading Financial Assets |
1,220,677.45 |
| Notes Receivable |
400,000.00 |
| Accounts Receivable |
1,008,388,772.65 |
| Advances to Suppliers |
31,231,627.61 |
| Other Receivables |
10,747,780.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
947,394,409.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,303,073.53 |
| Total Current Assets |
3,179,425,252.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,826,094.99 |
| Fixed Assetes |
1,701,217,367.77 |
| Under-construction Projects |
92,743,124.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
410,398,214.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
41,639,685.44 |
| Deferred Income Tax Assets |
37,189,473.08 |
| Other Non-Current Assets |
12,404,481.59 |
| Sub-Total of Non-Current Assets |
2,341,542,138.76 |
| Total Assets |
5,520,967,391.32 |
| Short-Term Loans |
929,209,519.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
898,997,541.62 |
| Accounts Payable |
774,170,723.59 |
| Accounts Received In Advance |
64,800.00 |
| Employee Compensation Payable |
49,887,787.49 |
| Taxes Payable |
16,227,179.56 |
| Interest Payable |
-- |
| Dividend Payable |
877,500.00 |
| Other payables |
48,696,603.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
152,295,867.73 |
| Other Current Liabilities |
3,154,102.35 |
| Sub-Total of Current Liabilities |
2,905,677,755.83 |
| Long-term Loans |
211,704,236.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
31,734,560.90 |
| Deferred Income Tax Liabilities |
31,443,722.85 |
| Other Non-Current Liabilities |
1,193,394.05 |
| Sub-Total of Non-Current Liabilities |
455,353,285.28 |
| Total Liabilities |
3,361,031,041.11 |
| Paid-In Capital(Or Share Stock) |
402,149,793.00 |
| Capital Surplus |
1,463,653,797.40 |
| Surplus Reserve |
140,493,876.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
148,004,595.04 |
| Minority Stockholder's Interest |
7,862,135.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,152,074,215.05 |
| Owner's Equity（Stockholder's Equity） |
2,159,936,350.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,520,967,391.32 |
